Griffithsin
|
WikiDoc Resources for Griffithsin |
|
Articles |
|---|
|
Most recent articles on Griffithsin Most cited articles on Griffithsin |
|
Media |
|
Powerpoint slides on Griffithsin |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Griffithsin at Clinical Trials.gov Clinical Trials on Griffithsin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Griffithsin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Griffithsin Discussion groups on Griffithsin Patient Handouts on Griffithsin Directions to Hospitals Treating Griffithsin Risk calculators and risk factors for Griffithsin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Griffithsin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Griffithsin, is a protein isolated from the red algae Griffithsia. It has a 121-amino acid sequence.[1] It has been shown in vitro to be a highly potent HIV entry inhibitor. It is currently being investigated as a potential microbicide for use in the prevention of the transmission of HIV.[2]
- ↑ Mori T, O'Keefe BR, Sowder RC; et al. (2005). "Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp". J. Biol. Chem. 280 (10): 9345–53. doi:10.1074/jbc.M411122200. PMID 15613479.
- ↑ Emau P, Tian B, O'keefe BR; et al. (2007). "Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide". J. Med. Primatol. 36 (4–5): 244–53. doi:10.1111/j.1600-0684.2007.00242.x. PMID 17669213.